When.com Web Search

  1. Ads

    related to: different brands of rescue inhalers for coronavirus for sale

Search results

  1. Results From The WOW.Com Content Network
  2. FDA approves generic to commonly used inhaler as demand ... - AOL

    www.aol.com/news/fda-approves-generic-commonly...

    The U.S Food and Drug Administration on Wednesday approved https://reut.rs/2RnpE3h first generic of a commonly used albuterol sulfate-based inhaler, catering to increased demand from COVID-19 ...

  3. List of medical inhalants - Wikipedia

    en.wikipedia.org/wiki/List_of_medical_inhalants

    Main page; Contents; Current events; Random article; About Wikipedia; Contact us; Help; Learn to edit; Community portal; Recent changes; Upload file

  4. Vicks - Wikipedia

    en.wikipedia.org/wiki/Vicks

    Vicks is an American brand of over-the-counter medications owned by the American companies Procter & Gamble and Kaz Incorporated.Vicks manufactures NyQuil and its sister medication, DayQuil as well as other medications in the "Quil" line.

  5. Dry-powder inhaler - Wikipedia

    en.wikipedia.org/wiki/Dry-powder_inhaler

    A dry-powder inhaler (DPI) is a device that delivers medication to the lungs in the form of a dry powder. DPIs are commonly used to treat respiratory diseases such as asthma , bronchitis , emphysema and COPD although DPIs (such as inhalable insulin ) have also been used in the treatment of diabetes mellitus .

  6. Some drugmakers to cap cost of asthma inhalers at $35 a month

    www.aol.com/news/drugmakers-cap-cost-asthma...

    Lucas’ doctor switched him to a different inhaler, from Merck, which cost $80 a month. Rix is now switching him to Symbicort, which will be capped at $35. ... Patients, said Conroy of Ohio State ...

  7. Boehringer to cut out-of-pocket costs for inhalers to $35 - AOL

    www.aol.com/news/boehringer-cut-pocket-costs...

    The company has cut out-of-pocket costs for its full range of inhaler products including Atrovent, Combivent and Spiriva, used to treat respiratory conditions such as asthma and chronic obst.

  8. Baricitinib - Wikipedia

    en.wikipedia.org/wiki/Baricitinib

    In May 2022, the FDA approved baricitinib for the treatment of COVID-19 in hospitalized adults requiring supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ECMO). [7] [14] [15] Baricitinib is the first immunomodulatory treatment for COVID-19 to receive FDA approval. [15]

  9. Teva Launches Two Digital Inhalers For Asthma Patients - AOL

    www.aol.com/news/teva-launches-two-digital...

    Teva Pharmaceutical Industries launched two new digital inhalers AirDuo Digihaler and ArmonAir Digihaler in the US for patients with Asthma. With these two launches, the company’s US affiliate ...